The Texas Children's Hospital (TCH) and Baylor College of Medicine (BCM) announced on Tuesday that Corbevax, a protein subunit Covid vaccine, has received approval from the Drugs Controller General of India (DCGI) to launch it in India. The initial construct and production process of the vaccine antigen was developed at TCH's Centre for Vaccine Development, led by co-directors Maria Elena Bottazzi and Peter Hotez.
from Top India News- News18.com https://ift.tt/3JpZ3fm
The Texas Children's Hospital (TCH) and Baylor College of Medicine (BCM) announced on Tuesday that Corbevax, a protein subunit Covid vaccine, has received approval from the Drugs Controller General of India (DCGI) to launch it in India. The initial construct and production process of the vaccine antigen was developed at TCH's Centre for Vaccine Development, led by co-directors Maria Elena Bottazzi and Peter Hotez.
atOptions = {
'key' : 'e35312e4c32833deb4e5e6059c69dbd4',
'format' : 'iframe',
'height' : 60,
'width' : 468,
'params' : {}
};
document.write('
Design by - Free Blogger Templates | Distributed by Blogger Templates